Nf1 mGBM cells have increased phosphorylation (activation) of NF-κB pathway intermediates relative to PDGFB mGBM cells (Figure 6A), consistent with a recent study showing that MES GBM GSCs exhibit constitutively active NF-κB signaling (33). This evidence concerns the gene PDGFB and glioblastoma.